The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 2002;346(8):634.

Clinical Implications of Basic Research
PreviousPrevious
Volume 345:1772-1774 December 13, 2001 Number 24
NextNext

Diabetes, Insulin Secretion, and the Pancreatic Beta-Cell Mitochondrion

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-PubMed Citation
Type 2 diabetes, the most common form of diabetes, affects about 135 million people worldwide. Insulin resistance and dysfunction of pancreatic beta cells are central abnormalities of the disease. Insulin resistance is a disordered state in which insulin inadequately stimulates glucose transport in skeletal muscle and fat and inadequately suppresses hepatic glucose production. Glucose intolerance and then diabetes develop as the compensatory hypersecretion of insulin by beta cells declines. Knowledge of the molecular control of insulin secretion is therefore important for understanding the beta-cell dysfunction of type 2 diabetes. Zhang et al. recently provided compelling evidence that a mitochondrial anion . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.